Skip to main content
. 2021 Jan 19;13(12):1067–1072. doi: 10.1136/neurintsurg-2020-017035

Table 1.

Demographic, clinical characteristics and treatment outcome

Primary isolated distal occlusion (group 1) Secondary DMVO following MT of a proximal vessel occlusion (group 2) Distal thrombectomy during elective AVM or aneurysm embolization (group 3)
Patient characteristics n=34 n=71 n=10
Age, mean (SD) 76 (12) 74 (15) 46 (17)
Female sex, n (%) 17 (50) 41 (57.8) 5 (50)
Prior IVT, n (%) 23 (67.6) 27 (38.0) NA
NIHSS at admission, median (range) 7 (0–22) 11 (0–31) NA
NIHSS at 24 hours, median (range) 6 (0–31) 8 (0–31) NA
NIHSS at discharge, median (range) 3 (0–31) 5 (0–23) NA
Successful recanalization (eTICI 2b67-3), n (%) 24 (70.5) 52 (73.2) 10 (100)
No of passes with Tigertriever 13, median (range) 2 (1–4) 1 (1–5) 1 (1–3)
Duration of MT procedure (min), mean (SD) 71 (50.1) 104 (68.2) NA
Contrast agent extravasation in CBCT immediately after thrombectomy, n (%) 16 (47.0) 31 (43.6) 0
Asymptomatic intracranial bleeding,* n (%) 7 (20.6) 12 (16.9) 0
Symptomatic intraparenchymal bleeding, n (%) 3 (8.8) 5 (7.0) 0
In-hospital mortality, n (%) 4 (11.8) 15 (21.1) NA

*Including subarachnoid and intra-parenchymal.

AVM, arteriovenous malformation; CBCT, cone-beam CT; DMVO, distal medium vessel occlusion; eTICI, extended Thrombolysis in Cerebral Infarction; IVT, intravenous thrombolysis; MT, mechanical thrombectomy.